Clinical Trials
Source: Solr
- Score: 1Prostate Cancer, Bladder Cancer
A Phase 1, First-in-Human, Dose-Escalation and Expansion Study of FX-909 in Patients With Advanced Solid Malignancies, Including Advanced Urothelial Carcinoma
- Score: 1Prostate Cancer
A Phase 1/2 Study of REGN5678 (Anti-PSMAxCD28) With Cemiplimab (Anti-PD-1) in Patients With Metastatic Castration-resistant Prostate Cancer
- Score: 1Children's Health, Kidney & Urinary Tract
Comparison of smart bedwetting alarm vs standard bedwetting alarm
- Ages6 years - 21 years
- GenderBoth
- Score: 1Other Cancers, Prostate Cancer
Customized Ablation of the Prostate With the TULSA Procedure Against Radical Prostatectomy Treatment: a Randomized Controlled Trial for Localized Prostate Cancer (CAPTAIN)
- Score: 1Prostate Cancer
MR-US Image Fusion Targeted Biopsy for Single-cell Prostate Cancer Research
- Ages18 years - 80 years
- GenderMale only
- Score: 1Prostate Cancer
Parallel Phase III Randomized Trials for High Risk Prostate Cancer Evaluating De-Intensification for Lower Genomic Risk and Intensification of Concurrent Therapy for Higher Genomic Risk With Radiation (PREDICT-RT*)
- Score: 1Kidney Cancer
Phase II Trial Of Stereotactic Body Radiation Therapy (SBRT) for Oligoprogression on Immune Checkpoint Inhibitors (ICI) in Metastatic Renal Cell Carcinoma
- Score: 1Prostate Cancer
Phase III Trial of Docetaxel vs. Docetaxel and Radium-223 for Metastatic Castration-Resistant Prostate Cancer (mCRPC)
- Ages18 years and older
- GenderMale only
- Score: 1Prostate Cancer
PRISM: Patient Experiences with PET Imaging in Prostate Cancer
- Score: 1Prostate Cancer
Prostate Cancer Outcomes: An International Registry to Improve Outcomes in Men With Advanced Prostate Cancer (IRONMAN)
- Ages21 years and older
- GenderMale only